SAN DIEGO, CA--(Marketwire - December 20, 2007) - Lpath, Inc. (OTCBB: LPTN), the category leader in therapeutic agents against bioactive lipids, today issued a review of recent progress with its various drug-development and drug-discovery programs and presented an update on the company's objectives for 2007.
